aod9604 clinical trial obesity AOD-9604 Peptide AOD 9604 Dosage: What It

Primary injection sites for AOD-9604 include the abdominal area (around the navel, varying position each injection), the front of the thighs (alternating legs), and the back of the upper arms (alternating arms)

However, although weight loss was observed in some studies, it did not occur in all studies (2)

About 5-Amino-1MQ Disclaimer: This is a chemical for research use only

Health Horizons USA

There are other 5-Amino-1MQ benefits due to its NNMT inhibition, including: Slowing down aging High NNMT levels reduce NAD+ and increase homocysteine (Hcy)

At the most basic level, NAD+ is required for turning the food you eat into usable energy